3-hydroxyisobutyric acid has been researched along with Insulin Resistance in 5 studies
3-hydroxyisobutyric acid: RN given refers to cpd without isomeric designation
3-hydroxyisobutyric acid : A 4-carbon, branched hydroxy fatty acid and intermediate in the metabolism of valine.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nilsen, MS | 1 |
| Jersin, RÅ | 1 |
| Ulvik, A | 1 |
| Madsen, A | 1 |
| McCann, A | 1 |
| Svensson, PA | 1 |
| Svensson, MK | 1 |
| Nedrebø, BG | 1 |
| Gudbrandsen, OA | 1 |
| Tell, GS | 1 |
| Kahn, CR | 1 |
| Ueland, PM | 1 |
| Mellgren, G | 1 |
| Dankel, SN | 2 |
| Bjune, MS | 1 |
| Lindquist, C | 1 |
| Hallvardsdotter Stafsnes, M | 1 |
| Bjørndal, B | 1 |
| Bruheim, P | 1 |
| Aloysius, TA | 1 |
| Nygård, O | 1 |
| Skorve, J | 1 |
| Madsen, L | 1 |
| Berge, RK | 1 |
| Haufe, S | 1 |
| Engeli, S | 1 |
| Kaminski, J | 1 |
| Witt, H | 1 |
| Rein, D | 1 |
| Kamlage, B | 1 |
| Utz, W | 1 |
| Fuhrmann, JC | 1 |
| Haas, V | 1 |
| Mähler, A | 1 |
| Schulz-Menger, J | 1 |
| Luft, FC | 1 |
| Boschmann, M | 1 |
| Jordan, J | 1 |
| Andersson-Hall, U | 1 |
| Gustavsson, C | 1 |
| Pedersen, A | 1 |
| Malmodin, D | 1 |
| Joelsson, L | 1 |
| Holmäng, A | 1 |
| Lyon, ES | 1 |
| Rivera, ME | 1 |
| Johnson, MA | 1 |
| Sunderland, KL | 1 |
| Vaughan, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Parallel Group Comparison on the Influence of a Low Carbohydrate and a Low Fat Hypocaloric 6 Months Diet on Body Weight Reduction, Metabolic and Cardiovascular Variables in Obese Healthy Women and Men.[NCT00956566] | 170 participants (Actual) | Interventional | 2007-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3-hydroxyisobutyric acid and Insulin Resistance
| Article | Year |
|---|---|
Branched-chain amino acid catabolism rather than amino acids plasma concentrations is associated with diet-induced changes in insulin resistance in overweight to obese individuals.
Topics: Adipose Tissue; Adult; Amino Acids, Branched-Chain; Biomarkers; Blood Glucose; Caloric Restriction; | 2017 |
4 other studies available for 3-hydroxyisobutyric acid and Insulin Resistance
| Article | Year |
|---|---|
3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism.
Topics: Adipocytes, Brown; Adipocytes, White; Amino Acids, Branched-Chain; Biomarkers; Body Composition; Cel | 2020 |
Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats.
Topics: Animals; Fatty Acids; Hydroxybutyrates; Insulin Resistance; Male; Methylmalonic Acid; Mitochondria, | 2021 |
Higher Concentrations of BCAAs and 3-HIB Are Associated with Insulin Resistance in the Transition from Gestational Diabetes to Type 2 Diabetes.
Topics: Adiponectin; Adult; Amino Acids, Branched-Chain; Blood Glucose; Body Mass Index; Diabetes Mellitus, | 2018 |
Actions of chronic physiological 3-hydroxyisobuterate treatment on mitochondrial metabolism and insulin signaling in myotubes.
Topics: Amino Acids, Branched-Chain; Animals; Cell Line; Dose-Response Relationship, Drug; Gene Expression; | 2019 |